Sue Desmond-Hellmann
American oncologist, academic, and nonprofit administrator (born 1958) / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Susan Desmond-Hellmann?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.[1]
Quick Facts Born, Education ...
Sue Desmond-Hellmann | |
---|---|
Born | 1958 (age 65–66) Napa, California, U.S. |
Education | University of Nevada, Reno (BS, MD) University of California, Berkeley (MPH) |
Close
Quick Facts External audio ...
External audio | |
---|---|
“Pandemic Perspectives: Interview with Sue Desmond-Hellmann”, May 14, 2020, Science History Institute. |
Close